Abstract
32P-Postlabeling analysis is an ultra-sensitive method for the detection of DNA adducts, such as those formed directly by the covalent binding of carcinogens and mutagens to bases in DNA, and other DNA lesions resulting from modification of bases by endogenous or exogenous agents (e.g., oxidative damage). The procedure involves four main steps: enzymatic digestion of DNA sample; enrichment of the adducts; radiolabeling of the adducts by T4 kinase-catalyzed transference of 32P-orthophosphate from [γ-32P]ATP; chromatographic separation of labeled adducts, and detection and quantification by means of their radioactive decay. Using 10 μg of DNA or less, it is capable of detecting adduct levels as low as 1 adduct in 109–1010 normal nucleotides. It is applicable to a wide range of investigations, including monitoring human exposure to environmental or occupational carcinogens, determining whether a chemical has genotoxic properties, analysis of the genotoxicity of complex mixtures, elucidation of the pathways of activation of carcinogens, and monitoring DNA repair.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Phillips DH (2002) The formation of DNA adducts. In: Allison MR (ed) The Cancer Handbook. Macmillan, London, pp 293–306
Strickland PT, Routledge MN, Dipple A (1993) Methodologies for measuring carcinogen adducts in humans. Cancer Epidemiol Biomarkers Prev 2:607–619
Poirier MC, Santella RM, Weston A (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21:353–359
Phillips, D.H. (2013) On the origins and development of the (32)P-postlabelling assay for carcinogen-DNA adducts. Cancer Lett, 334, 5–9
Phillips DH, Arlt VM (2007) The 32P-postlabeling assay for DNA adducts. Nat Protoc 2:2772–2781
Randerath K, Reddy MV, Gupta RC (1981) 32P-Labeling test for DNA damage. Proc Natl Acad Sci U S A 78:6126–6129
Gupta RC, Reddy MV, Randerath K (1982) 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3:1081–1092
Reddy MV, Randerath K (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543–1551
Gupta RC (1985) Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res 45:5656–5662
Randerath K, Randerath E, Danna TF, van Golen KL, Putman KL (1989) A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5′-monophosphates. Carcinogenesis 10:1231–1239
Pfau W, Lecoq S, Hughes NC, Seidel A, Platt KL, Grover PL, Phillips DH (1993) Separation of 32P-labelled 3′,5′-bisphosphate adducts by HPLC. In: Phillips DH, Castegnaro M, Bartsch H (eds) Postlabelling Methods for Detection of DNA Adducts. IARC, Lyon, pp 233–242
Phillips DH, Hewer A, Horton MN, Cole KJ, Carmichael PL, Davis W, Osborne MR (1999) N-Demethylation accompanies α-hydroxylation in the metabolic activation of tamoxifen in rat liver cells. Carcinogenesis 20:2003–2009
Nagy E, Cornelius MG, Moller L (2009) Accelerated (32)P-HPLC for bulky DNA adducts. Mutagenesis 24:183–189
Jones GD, Dickinson L, Lunec J, Routledge MN (1999) SVPD-post-labeling detection of oxidative damage negates the problem of adventitious oxidative effects during 32P-labeling. Carcinogenesis 20:503–507
Beach AC, Gupta RC (1992) Human biomonitoring and the 32P-postlabelling assay. Carcinogenesis 13:1053–1074
Phillips DH (1997) Detection of DNA modifications by the 32P-postlabelling assay. Mutat Res 378:1–12
Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen 35:222–233
Phillips DH, Castegnaro M (1993) Results of an interlaboratory trial of 32P-postlabelling. In: Phillips DH, Castegnaro M, Bartsch H (eds) Postlabelling Methods for Detection of DNA Damage. IARC, Lyon, pp 35–49
Phillips DH, Castegnaro M (1999) Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14:301–315
Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B, Marques MM (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem Res Toxicol 12:68–77
Osborne MR, Phillips DH (2000) Preparation of a methylated DNA standard, and its stability on storage. Chem Res Toxicol 13:257–261
Mourato LLG, Beland FA, Marques MM (1999) 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies. Chem Res Toxicol 12:661–669
Munnia A, Saletta F, Allione A, Piro S, Confortini M, Matullo G, Peluso M (2007) 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis 22:381–385
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Phillips, D.H., Arlt, V.M. (2020). 32P-Postlabeling Analysis of DNA Adducts. In: Keohavong, P., Singh, K., Gao, W. (eds) Molecular Toxicology Protocols. Methods in Molecular Biology, vol 2102. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0223-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0223-2_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0222-5
Online ISBN: 978-1-0716-0223-2
eBook Packages: Springer Protocols